Metabolite information |
|
HMDB ID | HMDB0000912 |
Synonyms |
(S)-N-(1,2-Dicarboxyethyl)-adenosine6-(1,2-dicarboxyethylamino)-9-b-D-Ribofuranosylpurine6-(1,2-dicarboxyethylamino)-9-beta-D-Ribofuranosylpurine6-(1,2-dicarboxyethylamino)-9-beta-delta-Ribofuranosylpurine6-(1,2-dicarboxyethylamino)-9-β-D-ribofuranosylpurineN-(9-b-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartateN-(9-b-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartic acidN-(9-beta-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartateN-(9-beta-D-Ribofuranosyl-9H-purin-6-yl)-L-aspartic acidN-(9-beta-delta-Ribofuranosyl-9H-purin-6-yl)-L-aspartateN-(9-beta-delta-Ribofuranosyl-9H-purin-6-yl)-L-aspartic acidN-(9-β-D-ribofuranosyl-9H-purin-6-yl)-L-aspartateN-(9-β-D-ribofuranosyl-9H-purin-6-yl)-L-aspartic acidN-9-Ribofuranosyl-9H-purin-6-yl-aspartateN-9-Ribofuranosyl-9H-purin-6-yl-aspartic acidSuccinoadenosine |
Chemical formula | C14H17N5O8 |
IUPAC name | (2S)-2-({9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-yl}amino)butanedioic acid |
CAS registry number | 4542-23-8 |
Monoisotopic molecular weight | 383.107712545 |
Chemical taxonomy |
|
Super class | Nucleosides, nucleotides, and analogues |
Class | Purine nucleosides |
Sub class | – |
Biological properties |
|
Pathways (Pathway Details in HMDB) |
|
Reference | Country | Specimen | Marker function | Participants (Case) | Participants (Control) | |||||||||
Cancer type | Stage | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | Type | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | ||||
An et al. 2010 | China | urine | diagnosis | adenocarcinoma, squamous cell carcinoma, SCLC | – | 19 | – | 61 ± 8.4 | – | healthy | 22 | – | – | – |
Moreno et al. 2018 | Spain | tissue | therapy, diagnosis | squamous cell carcinoma | I, II, III | 35 | 35, 0 | 68.71 ± 7.46 | – | tumor vs. adjacent normal tissue | 35 | 35, 0 | 68.71 ± 7.46 | – |
Reference | Chromatography | Ion source | Positive/Negative mode | Mass analyzer | Identification level |
An et al. 2010 | LC | ESI | positive | Q-TOF | MS/MS |
Moreno et al. 2018 | LC, GC | ESI, EI | both | LC: linear ion-trap, GC: single-quadrupole | LC: MS/MS |
Reference | Data processing software | Database search |
An et al. 2010 | MZmine 2 beta | HMDB, PubChem compound database, METLIN, KEGG |
Moreno et al. 2018 | – | KEGG, HMDB |
Reference | Difference method | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
An et al. 2010 | independent t-test | – | – | – | 0.02 | – | – |
Moreno et al. 2018 | paired two-sample t-test, PLS-DA | – | – | 2.40 | 4.54e-09 | 1.84e-08 | – |
Reference | Classification method | Cutoff value | AUROC 95%CI | Sensitivity (%) | Specificity (%) | Accuracy (%) |
An et al. 2010 | – | – | – | – | – | – |
Moreno et al. 2018 | – | – | – | – | – | – |